2002

Oct 11, 2002
Guidant Receives FDA Approval for its Next Generation Heart Failure Technology

Small, Physiologic-shaped CONTAK CD 2 System Combines Treatment for Both Heart Failure and Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Oct 9, 2002
Guidant Announces Live Webcast of its Third Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2002 earnings...

Oct 3, 2002
Guidant Receives Humanitarian Device Exemption for New Intracranial Stent

NEUROLINK Stent May Provide Hope for Patients at High Risk for Recurrent Stroke Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Oct 2, 2002
Guidant Comments on Cook-Boston Scientific Litigation

Conference Call/Webcast Scheduled at 11AM EDT Today Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) reported that the United States District Court for the Northern District of...

Oct 1, 2002
Guidant Announces European Market Launch of Next-Generation Implantable Defibrillators

World''s smallest, thinnest defibrillator offers advanced rhythm discrimination and industry-leading longevity Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a...

Show 5102550100 per page
Top